Chelation therapy with deferasirox versus deferoxamine in transfusion-dependent sickle-cell disease: a cost-effectiveness analysis from the US perspective

Policy Analysis Inc. (PAI), Four Davis Court, Brookline, MA 02445 USA. tdelea@pai2.com

Haematologica. 2006;91((Suppl 1):): Abstract No. 0003.
Study details
Study Design : Economic Study